Article Information
History
- January 2, 2024.
Copyright
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-NC 4.0 International license.
Author Information
- Inayat Bhardwaj1,†,
- Prince B. Nyarko1,†,
- Asrar Ba Ashn1,
- Camille Cohen1,
- Sukai Ceesay3,
- Jane Achan3,
- Edgard Dabira3,
- Rike Nakajima5,
- Aarti Jain5,
- Omid Taghavian5,
- Algis Jasinskas5,
- Philip L. Felgner5,
- Umberto D’Alessandro3,
- Teun Bousema4,
- Mark Travassos2,
- Ovidiu Radulescu1,‡ and
- Antoine Claessens1,3,4,‡
- 1LPHI University of Montpellier and CNRS, Montpellier, France
- 2Malaria Research Program, Center for Vaccine Development and Global Health, University of Maryland School of Medicine, Baltimore, United States of America
- 3Medical Research Council Unit The Gambia at the London School of Hygiene and Tropical Medicine, Banjul, The Gambia
- 4Department of Medical Microbiology and Radboud Center for Infectious Diseases, Radboud University Medical Center, Nijmegen, The Netherlands
- 5Vaccine Research & Development Center, Department of Physiology & Biophysics, School of Medicine, University of California, Irvine, Irvine, California, United States of America
- ↵‡corresponding author ovidiu.radulescu{at}umontpellier.fr, antoine.claessens{at}umontpellier.fr
↵† equal contribution